Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2016 Mar 11.

Published in final edited form as: Curr Alzheimer Res. 2015;12(7):640–647. doi: 10.2174/1567205012666150701102325

Table 1.

Metabolic Syndrome (MetS) Group Characteristics

	No Risk (0 MetS criteria) n=20	Low Risk (1–2 MetS criteria) n=60	High Risk (3+ MetS criteria) n=39
Group Characteristics
Age (years)^a	53.5±14.2	62.8±12.4	60.6±12.3
Education (years)	15.5±3.1	15.3±2.7	14.1±2.4
Sex (M:F)	6:14	31:29	17:22
Race (B:W)	6:14	30:30	21:18
pVIQ^b	110.5±10.1	106.1±13.1	99.1±15.0
Diabetes Presence (%)	0%	31%	80%
Diabetes Duration (months)	n/a	29.3±57.9	72.2±72.6
CIRS^b	2.2±2.1	5.0±3.2	7.0±3.5
Criterion Met (%)
HDL	0	13	66
Glucose	0	36	66
HTN	0	66	77
Triglyceride	0	8	74
BMI	0	35	77

^a

p<.05;

^b

p≤.005;

M:F=male:female; B:W=black:white;

pVIQ=predicted verbal IQ; CIRS=Cumulative Illness Rating Scale.